✨ Consent to Distribution of New Medicines




NEW ZEALAND GAZETTE, No. 19 β€” 23 FEBRUARY 2017

Any person wishing to make representations to the Minister of Transport relating to this application must forward those representations in writing to reach me at the Ministry of Transport, PO Box 3175, Wellington, or email airservices@transport.govt.nz, on or before 17 March 2017.

Signed at Wellington this 17th day of February 2017.

SONYA VAN DE GEER, Principal Adviser, Aviation and Security, Ministry of Transport.

2017-go796


Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:

Schedule

Product:
Plasma-Lyte 148, pH 7.4

Active Ingredients:
Magnesium chloride hexahydrate 0.3g/L
Potassium chloride 0.37g/L
Sodium acetate trihydrate 3.68g/L
Sodium chloride 5.26g/L
Sodium gluconate 5.02g/L

Dosage Form:
Solution for infusion

New Zealand Sponsor:
Baxter Healthcare Limited

Manufacturer:
Baxter Healthcare Pty Limited, Sydney, Australia

Product:
Potassium 40mmol and 0.9% Sodium Chloride

Active Ingredients:
Potassium chloride 29.8g/L
Sodium chloride 9g/L

Dosage Form:
Solution for infusion

New Zealand Sponsor:
Baxter Healthcare Limited

Manufacturer:
Baxter Healthcare Pty Limited, Sydney, Australia

Product:
Potassium Chloride 20mmol in 4% Glucose and 0.18% Sodium Chloride

Active Ingredients:
Glucose 40g/L
Potassium chloride 1.5g/L
Sodium chloride 1.8g/L

Dosage Form:
Solution for infusion

New Zealand Sponsor:
Baxter Healthcare Limited

Manufacturer:
Baxter Healthcare Pty Limited, Sydney, Australia

Product:
Potassium Chloride 30mmol in 4% Glucose and 0.18% Sodium Chloride (Baxter)

Active Ingredients:
Glucose 40g/L
Potassium chloride 2.24g/L
Sodium chloride 1.8g/L

Dosage Form:
Solution for infusion

New Zealand Sponsor:
Baxter Healthcare Limited

Manufacturer:
Baxter Healthcare Pty Limited, Sydney, Australia

Product:
Tygacil

Active Ingredients:
Tigecycline 50mg

Dosage Form:
Powder for infusion

New Zealand Sponsor:
Pfizer New Zealand Limited

Manufacturers:
Patheon Italia SpA, Milan, Italy
Wyeth Lederle S.r.L, Catania, Italy

Dated this 17th day of February 2017.

CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).

2017-go800

60



Next Page →



Online Sources for this page:

Gazette.govt.nz PDF NZ Gazette 2017, No 19





✨ LLM interpretation of page content

πŸ₯ Consent to the Distribution of New Medicines

πŸ₯ Health & Social Welfare
17 February 2017
Medicines Act 1981, Medicines, Distribution, Consent, Medsafe, Baxter Healthcare, Pfizer
  • CHRIS JAMES, Group Manager, Medsafe, Ministry of Health